Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Dextromethorphan in smoking related cough
ISRCTN ISRCTN46985377
ClinicalTrials.gov identifier
Public title Dextromethorphan in smoking related cough
Scientific title A single centre, randomised, double blind, placebo controlled, crossover, pilot study to determine the efficacy and safety of dextromethorphan versus placebo for the treatment of smoking related cough
Acronym N/A
Serial number at source N0084120889
Study hypothesis This project was undertaken to evaluate the efficacy of dextromethorphan in the optimised cough formulation compared to placebo in a group of subjects with smoking related cough.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Respiratory: Smoking related cough
Participants - inclusion criteria 50 volunteers between 18 - 70 years.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 11/03/2003
Anticipated end date 01/06/2004
Status of trial Completed
Patient information material
Target number of participants 42
Interventions Dextromethorphan versus placebo.
Primary outcome measure(s) Reduction in cough frequency measured subjectively after waking on treatment day 1 over time periods 0 - 10, 10 - 20, 20 - 40 and 40 - 60 minutes.
Secondary outcome measure(s) 1. Reduction in cough frequency on days 2 - 5
2. Change in cough symptoms (severity expectoration, chest pain, etc.,) and nocturnal cough
3. Change in cough threshold as measured via citric acid cough challenge
Sources of funding 1. The North and South Bank Research and Development Consortium (NHS R&D Support Funding) (UK)
2. Procter & Gamble (UK)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/18279476
Contact name Miss  Caroline  Wright
  Address Academic Department of Medicine
Castle Hill Hospital
Castle Road
  City/town Cottingham, East Yorkshire
  Zip/Postcode HU16 5JQ
  Country United Kingdom
  Fax +44 (0)1482 622248
  Email c.e.wright@hull.ac.uk
Sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 12/09/2003
Last edited 22/02/2008
Date ISRCTN assigned 12/09/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central